Table 4.
Author; year | Animal or cell | Active components | Factors and pathways |
---|---|---|---|
Wu et al. [31]; 2010 | CCl4-induced liver inflammation and fibrosis rats | Saikosaponin a | Proinflammatory cytokines TNF-α, IL-1β, IL-6↓; anti-inflammatory cytokine IL-10↑; TGF-β1 and hydroxyproline↓; NF-κB↓ |
Dang et al. [32]; 2007 | Liver fibrotic rats | Saikosaponin d | TNF-α, IL-6 and NF-κBp65 expression↓; I-κBα activity↑ |
Sun et al. [56]; 2010 | CCl4-induced liver fibrosis rats | Baicalein | AST, ALT, hyaluronic acid, laminin, and PDGF-β receptor↓; hydroxyproline, MMPs↓ |
Qiao et al. [60]; 2011 | CCl4-induced liver injury rats | Baicalin | PPARγ↑; TGFβ1↓ |
Kim and Lee [62]; 2012 | Ischemia/reperfusion injured rats with alcoholic fatty liver | Baicalin | Toll-like receptor 4 (TLR4)↓; myeloid differentiation primary response protein My88↓ |
Lo et al. [75]; 2011 | HSCs | Ginsenoside Rb1 | HSCs activation and proliferation↓; expression of collagen, TGF-β1, MMP-2, and TIMP-1↓ |
Geng et al. [76]; 2010 | Thioacetamide-treated rats; HSCs | Ginsenoside Rg1 | AST, ALT, hydroxyproline↓; HSCs↓; PDGF-β receptor expression↓ |
Sabina et al. [83]; 2011 | Acetaminophen-treated mice | 6-gingerol | The hepatic marker enzymes (AST, ALT, and ALP) and total bilirubin in serum↓; hepatic malondialdehyde formation↓; liver antioxidant status↑ |
Gumpricht et al. [86]; 2005 | Rat hepatocytes exposed to GCDC | Glycyrrhizin; 18-beta-glycyrrhetinic acid |
Glycyrrhizin-enhanced GCDC induced cell apoptosis; 18-beta-glycyrrhetinic acid reduced cell necrosis and protected against GCDC-induced cell apoptosis |
Lee et al. [87]; 2007 | CCl4-induced liver injury rats | Glycyrrhizin | Liver function improvement; proinflammatory mediators (TNF-α, inducible nitric oxide synthase, and COX-2)↓; heme oxygenase-1↑; |